Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)
This study has been terminated.
( Based on the data and observed benefit-risk profile, the trial's independent oversight committee recommended that enrollment not resume. )
Study NCT00073372   Information provided by Centocor, Inc.
First Received: November 19, 2003   Last Updated: March 17, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Brain Ischemia
Cerebrovascular Accident
Acute Disease
Additional conditions recognized in this trial
Cerebral Infarction
Ischemia
Stroke
More general conditions related to this trial
Brain Diseases
Brain Infarction
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Disease Attributes
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Abciximab
More general drug interventions related to this trial
Anticoagulants
Hematologic Agents
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Centocor, Inc.
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services